Search Results

Aripiprazole: Hyperamylasaemia (first report) and hyperlipaseaemia: case report

Source: Reactions, Volume 1, Number 1282, 2009-12-12 , pp. 11-11(1)

Publisher: Adis International

Aripiprazole: Catatonia: case report

Source: Reactions, Volume 1, Number 1282, 2009-12-12 , pp. 11-11(1)

Publisher: Adis International

Aripiprazole: Priapism: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 10-10(1)

Publisher: Adis International

Adverse Endocrine and Metabolic Effects of Psychotropic Drugs: Selective Clinical Review

Authors: Bhuvaneswar, Chaya G.; Baldessarini, Ross J.; Harsh, Veronica L.; Alpert, Jonathan E.

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1003-1021(19)

Publisher: Adis International

Olanzapine/risperidone: Pisa syndrome and tardive dyskinesia, treated with aripiprazole: case report

Source: Reactions, Volume 1, Number 1281, 2009-12-05 , pp. 24-24(1)

Publisher: Adis International

Risperidone: Tardive parkinsonism, treated with aripiprazole: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 35-36(2)

Publisher: Adis International

Improvement of restless legs syndrome and trichotillomania with aripiprazole

Authors: Virit, O.; Selek, S.; Savas, H. A.; Kokaçya, H.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 6, December 2009 , pp. 723-725(3)

Publisher: Blackwell Publishing

Aripiprazole: Mania?: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 8-8(1)

Publisher: Adis International

Aripiprazole/haloperidol/lithium: Movement disorders, polyuria and polydypsia, and Pisa syndrome after switching from haloperidol to aripiprazole: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 8-8(1)

Publisher: Adis International

Aripiprazole/quetiapine: Urinary bladder rupture associated with fecaloma causing sudden death: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 9-9(1)

Publisher: Adis International

Olanzapine increases risk of diabetes

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 6-6(1)

Publisher: Adis International

Antipsychotics: Metabolic disorders, tardive dyskinesia and obsessive-compulsive symptoms (first report with ziprasidone): case report

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 9-9(1)

Publisher: Adis International

Aripiprazole: First report of acute myopia: case report

Source: Reactions, Volume 1, Number 1272, 2009-10-03 , pp. 8-8(1)

Publisher: Adis International

Aripiprazole: Dystonia and akathisia: case report

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 8-8(1)

Publisher: Adis International

Aripiprazole Loaded Polymeric Biodegradable Microspheres: Formulation and In Vitro Characterization

Authors: Talegaonkar, Sushama; Mittal, Ashu; Parmar, Shikha; Aqil, Mohammed

Source: Journal of Dispersion Science and Technology, Volume 30, Number 8, September 2009 , pp. 1198-1202(5)

Publisher: Taylor and Francis Ltd

The All Wales Medicines Strategy Group recommendations have been ministerially ratified, allowing the targeted use of two further medications in Wales

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 11-11(1)

Publisher: Adis International

Comparative Utility of Aripiprazole and Haloperidol in Schizophrenia: Post Hoc Analysis of Two 52-Week, Randomized, Controlled Trials

Authors: Kane, John M.; Kim, Edward; Kan, Hong J.; Guo, Zhenchao; Bates, John A.; Whitehead, Richard; Pikalov, Andrei

Source: Applied Health Economics and Health Policy, Volume 7, Number 2, 1 June 2009 , pp. 109-119(11)

Publisher: Adis International

Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole

Authors: Rainka, M. M.; Capote, H. A.; Ross, C. A.; Gengo, F. M.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 5, October 2009 , pp. 595-598(4)

Publisher: Blackwell Publishing

Optimize the benefits and minimize the adverse effects of antipsychotics in patients with acute schizophrenia

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 10, October 2009 , pp. 12-16(5)

Publisher: Adis International

Quantifying Risk: The Role of Absolute and Relative Measures in Interpreting Risk of Adverse Reactions from Product Labels of Antipsychotic Medications

Author: Citrome, Leslie

Source: Current Drug Safety, Volume 4, Number 3, September 2009 , pp. 229-237(9)

Publisher: Bentham Science Publishers